CHINA PHARMA HOLDINGS, INC. Annual Amortization of Intangible Assets in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
China Pharma Holdings, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from 2016 to 2023.
  • China Pharma Holdings, Inc. Amortization of Intangible Assets for the quarter ending June 30, 2024 was $105K, a 90.2% increase year-over-year.
  • China Pharma Holdings, Inc. annual Amortization of Intangible Assets for 2023 was $224K, a 512% increase from 2022.
  • China Pharma Holdings, Inc. annual Amortization of Intangible Assets for 2022 was $36.6K, a 4.08% decline from 2021.
  • China Pharma Holdings, Inc. annual Amortization of Intangible Assets for 2021 was $38.1K, a 6.91% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $224K +$187K +512% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $36.6K -$1.56K -4.08% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $38.1K +$2.46K +6.91% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $35.7K -$22K -38.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 $57.7K -$57.5K -49.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-26
2018 $115K -$50.3K -30.4% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
2017 $165K -$97.5K -37.1% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-28
2016 $263K Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.